TRVI

Trevi Therapeutics (TRVI)

Trevi Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TRVI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/25	05:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/05/24	20:30	Business Wire	FNB Harvest annonce les distributions de mai 2024	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/05/22	07:34	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/05/09	20:30	PR Newswire (US)	Trevi Therapeutics to Participate in Upcoming Conferences	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/05/08	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/05/08	05:05	PR Newswire (US)	Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/05/02	05:05	PR Newswire (US)	Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/04/23	20:30	Business Wire	FNB Harvest annonce les distributions d’avril 2024	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/04/09	20:30	PR Newswire (US)	Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/04/04	20:30	PR Newswire (US)	Trevi Therapeutics to Participate in Upcoming April Events	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/04/02	20:30	PR Newswire (US)	Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/03/21	20:30	Business Wire	FNB Harvest annonce les distributions de mars 2024	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/03/21	05:05	PR Newswire (US)	Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/03/14	05:05	PR Newswire (US)	Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/28	21:30	PR Newswire (US)	Trevi Therapeutics to Participate in Upcoming March Events	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/22	21:30	Business Wire	FNB Harvest annonce les distributions de février 2024	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/17	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/17	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/17	06:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/15	10:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/15	05:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/02/06	21:30	PR Newswire (US)	Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/01/24	21:30	Business Wire	FNB Harvest annonce les distributions de janvier 2024	NASDAQ:TRVI	Trevi Therapeutics Inc
2024/01/04	21:30	PR Newswire (US)	Trevi Therapeutics Provides Business Updates	NASDAQ:TRVI	Trevi Therapeutics Inc
2023/12/30	00:26	Business Wire	FNB Harvest annonce les distributions annuelles finales réinvesties pour 2023	NASDAQ:TRVI	Trevi Therapeutics Inc
2023/12/22	06:33	Business Wire	FNB Harvest Distributions réinvesties annuelles estimatives révisées pour 2023	NASDAQ:TRVI	Trevi Therapeutics Inc
2023/12/18	21:30	Business Wire	FNB Harvest annonce les distributions de décembre 2023	NASDAQ:TRVI	Trevi Therapeutics Inc
2023/12/05	21:30	PR Newswire (US)	Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)	NASDAQ:TRVI	Trevi Therapeutics Inc
2023/12/01	05:14	Business Wire	FNB Harvest Distributions réinvesties annuelles estimées pour 2023	NASDAQ:TRVI	Trevi Therapeutics Inc
2023/11/17	21:30	Business Wire	FNB Harvest annonce les distributions de novembre 2023	NASDAQ:TRVI	Trevi Therapeutics Inc